Scantox’s Pharmaceutical Development & Analytical division provides integrated expertise across formulation development, GMP manufacturing, analytical development, quality control, and bioanalysis. We support drug candidates from concept through clinical proof of concept, applying scientific rigor, regulatory compliance, and flexible collaboration.
Our teams specialize in small‑molecule development, offering pre‑formulation studies, analytical method development, QC testing, ICH‑aligned stability programs, and LC‑MS/MS bioanalysis. Scantox is known for reliable timelines, responsive communication, and tailored scientific solutions aligned with EMA and ICH expectations.
